Table 3. Symptom frequency in subjects with co-infection, dengue virus (DENV) mono-infection, and Plasmodium mono-infection.
| Symptoms | Co-infection n/total (%) | DENV n/total (%) | Plasmodium n/total (%) | p value* |
|---|---|---|---|---|
| Abdominal pain | 8/17 (47%) | 15/51 (29%) | 21/44 (48%) | 0.1033 |
| Epistaxis*** | 1/17 (7%) | 1/51 (2%) | 0/44 (0%) | 0.282 |
| Prostration | 2/15 (13%) | 2/51 (4%) | 3/41 (7%) | 0.5625 |
| Asthenia | 9/16 (56%) | 23/51 (45%) | 18/44 (41%) | 0.3873 |
| Chills | 15/17 (88%) | 48/51 (94%) | 41/44 (93%) | 0.7081 |
| Malaise | 15/16 (94%) | 50/51 (98%) | 41/41 (100%) | 0.4286 |
| Pallor | 5/16 (31%) | 11/51 (22%) | 18/44 (41%) | 0.2133 |
| Rash | 2/16 (13%) | 2/51 (4%) | 0/41 (0%) | 0.0445 |
| Arthralgia | 14/16 (88%) | 48/51 (94%) | 39/44 (87%) | 0.4844 |
| Myalgia | 13/16 (81%) | 45/51 (88%) | 30/44 (68%) | 0.031** |
| Diarrhea | 4/17 (24%) | 7/51 (14%) | 7/44 (16%) | 0.6376 |
| Nausea | 13/17 (76%) | 36/51 (71%) | 28/44 (64%) | 0.4135 |
| Vomiting | 8/17 (47%) | 23/51 (45%) | 16/44 (36%) | 0.2949 |
| Rhinorrhea | 2/16 (13%) | 4/50 (8%) | 6/44 (14%) | 0.8348 |
| Cough | 5/16 (31%) | 5/51 (10%) | 15/44 (34%) | 0.010** |
| Expectoration | 1/16 (6%) | 2/51 (4%) | 3/44 (7%) | 0.8648 |
| Headache | 16/16 (100%) | 51/51 (100%) | 42/44 (95%) | 0.1837 |
| Eye pain | 10/15 (67%) | 40/51 (78%) | 28/41 (68%) | 0.455 |
* Conditional logistic regression, matched analyses
** Dengue virus mono-infection different from Plasmodium mono-infection
*** No recorded cases of gum bleeding, hematochezia, or hematuria